These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 29131690)
1. Investigating ioflupane I Reams N; Anderson J; Perlman R; Li W; Walters S; Tideman S; Wang C; Simon K; Frigerio R; Maraganore DM Brain Inj; 2018; 32(1):105-112. PubMed ID: 29131690 [TBL] [Abstract][Full Text] [Related]
2. SPECT study with I-123-Ioflupane (DaTSCAN) in patients with essential tremor. Is there any correlation with Parkinson's disease? Gerasimou G; Costa DC; Papanastasiou E; Bostanjiopoulou S; Arnaoutoglou M; Moralidis E; Aggelopoulou T; Gotzamani-Psarrakou A Ann Nucl Med; 2012 May; 26(4):337-44. PubMed ID: 22382608 [TBL] [Abstract][Full Text] [Related]
3. Discriminating among degenerative parkinsonisms using advanced (123)I-ioflupane SPECT analyses. Badoud S; Van De Ville D; Nicastro N; Garibotto V; Burkhard PR; Haller S Neuroimage Clin; 2016; 12():234-40. PubMed ID: 27489771 [TBL] [Abstract][Full Text] [Related]
4. Clinical Impact of 123I-Ioflupane SPECT (DaTscan) in a Movement Disorder Center. Graebner AK; Tarsy D; Shih LC; Vanderhorst V; Kulkarni O; Kaplan S; Simon DK Neurodegener Dis; 2017; 17(1):38-43. PubMed ID: 27614874 [TBL] [Abstract][Full Text] [Related]
5. Importance of (123)I-ioflupane SPECT and Myocardial MIBG Scintigraphy to Determine the Candidate of Deep Brain Stimulation for Parkinson's Disease. Asahi T; Kashiwazaki D; Yoneyama T; Noguchi K; Kuroda S Neurol Med Chir (Tokyo); 2016; 56(3):125-31. PubMed ID: 26794041 [TBL] [Abstract][Full Text] [Related]
7. Microvascular and large vein abnormalities in young patients after mild head trauma and associated fatigue: A brain SPECT evaluation and posture dependence modeling. Crider T; Eng D; Sarkar PR; Cordero J; Krusz JC; Sarkar SN Clin Neurol Neurosurg; 2018 Jul; 170():159-164. PubMed ID: 29800829 [TBL] [Abstract][Full Text] [Related]
9. [[(123)I]-Ioflupane SPECT in combination with MIBG myocardial scintigraphy in Parkinson's disease: a case series study]. Yamada A; Murakami T; Kang Y; Iikuni Y; Morimatsu A; Shirata A; Ito H; Ugawa Y; Yamane K Rinsho Shinkeigaku; 2016 Jun; 56(6):400-6. PubMed ID: 27212677 [TBL] [Abstract][Full Text] [Related]
10. Experience with DaTscan at a tertiary referral center. Sadasivan S; Friedman JH Parkinsonism Relat Disord; 2015 Jan; 21(1):42-5. PubMed ID: 25465746 [TBL] [Abstract][Full Text] [Related]
11. Dopamine Transporter Imaging has no Impact on Functional Outcomes in de Novo Probable Parkinson's Disease. Hickey PT; Kuchibhatla M; Scott B; Gauger L; Stacy MA J Parkinsons Dis; 2017; 7(2):279-287. PubMed ID: 28339403 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of an Objective Striatal Analysis Program for Determining Laterality in Uptake of ¹²³I-Ioflupane SPECT Images: Comparison to Clinical Symptoms and to Visual Reads. Kuo PH; Lei HH; Avery R; Krupinski EA; Bauer A; Sherman S; McMillan N; Seibyl J; Zubal GI J Nucl Med Technol; 2014 Jun; 42(2):105-8. PubMed ID: 24627411 [TBL] [Abstract][Full Text] [Related]
13. Distinct spatiotemporal patterns for disease duration and stage in Parkinson's disease. Badoud S; Nicastro N; Garibotto V; Burkhard PR; Haller S Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):509-16. PubMed ID: 26318603 [TBL] [Abstract][Full Text] [Related]
14. 123I-FP-CIT brain SPECT (DaTSCAN) imaging in the diagnosis of patients with movement disorders--first results. Jauković L; Ilić TV; Dopudja M; Ajdinović B Vojnosanit Pregl; 2012 Feb; 69(2):157-62. PubMed ID: 22500370 [TBL] [Abstract][Full Text] [Related]
15. The impact of DaTscan in the diagnosis of Parkinson disease. Gayed I; Joseph U; Fanous M; Wan D; Schiess M; Ondo W; Won KS Clin Nucl Med; 2015 May; 40(5):390-3. PubMed ID: 25783511 [TBL] [Abstract][Full Text] [Related]
16. Genome-wide variant by serum urate interaction in Parkinson's disease. Nazeri A; Roostaei T; Sadaghiani S; Chakravarty MM; Eberly S; Lang AE; Voineskos AN Ann Neurol; 2015 Nov; 78(5):731-41. PubMed ID: 26284320 [TBL] [Abstract][Full Text] [Related]
17. The brain scintiscan with iodine-123-ioflupane to diagnose early Parkinson's disease; seven months follow up. First results in Bulgaria. Piperkova E; Georgiev R; Daskalov M; Stamenova P; Katerinski K; Beeva M; Orozova M; Dimitrova M Hell J Nucl Med; 2006; 9(1):31-5. PubMed ID: 16617391 [TBL] [Abstract][Full Text] [Related]
18. Prospective study of presynaptic dopaminergic imaging in patients with mild parkinsonism and tremor disorders: part 1. Baseline and 3-month observations. Benamer HT; Oertel WH; Patterson J; Hadley DM; Pogarell O; Höffken H; Gerstner A; Grosset DG Mov Disord; 2003 Sep; 18(9):977-84. PubMed ID: 14502664 [TBL] [Abstract][Full Text] [Related]
19. [Elaboration of the SPM template for the standardization of SPECT images with 123I-Ioflupane]. García-Gómez FJ; García-Solís D; Luis-Simón FJ; Marín-Oyaga VA; Carrillo F; Mir P; Vázquez-Albertino RJ Rev Esp Med Nucl Imagen Mol; 2013; 32(6):350-6. PubMed ID: 23570700 [TBL] [Abstract][Full Text] [Related]